A drug-drug interaction study to evaluate the effects of strong CYP3A4 inducer on the pharmacokinetics of segesterone acetate and ethinyl estradiol in a contraceptive vaginal system. [PDF]
Plagianos M +8 more
europepmc +1 more source
Portal Venous Thrombosis Associated with Use of Etonogestrel/ethinyl Estradiol Vaginal Ring. [PDF]
Bailey KE, Tranovich MJ.
europepmc +1 more source
Oral contraceptives containing ethinyl estradiol and drospirenone increase hydroxylation and methylation of endogenous estrogen but not genotoxic estrogen DNA-adduct formation. [PDF]
Venter G +4 more
europepmc +1 more source
Contraceptive hormone ethinyl estradiol but not levonorgestrel modulates the role of reinforcer-enhancement in nicotine self-administration in ovary-intact female Sprague-Dawley rats. [PDF]
McNealy KR +5 more
europepmc +1 more source
Use of an Ethinyl Estradiol/Etonogestrel Vaginal Ring Alters Vaginal Microbial Communities in Women With HIV. [PDF]
Tobin NH +13 more
europepmc +1 more source
Oral ethinyl estradiol treatment in women with cystic fibrosis is associated with lower bone mineral density. [PDF]
Wu M, Hunt WR, Putman MS, Tangpricha V.
europepmc +1 more source
Effects of multiple-dose administration of zavegepant nasal spray on the single-dose pharmacokinetics of ethinyl estradiol-levonorgestrel. [PDF]
Bhardwaj R +5 more
europepmc +1 more source
Glecaprevir-Pibrentasvir and Ethinyl Estradiol-Induced Liver Injury in a Patient Without Cirrhosis. [PDF]
Wiese J +4 more
europepmc +1 more source
Effects of a Monophasic Hormonal Contraceptive With Norgestimate+Ethinyl Estradiol on Menstrual Bleeding: Protocol and Design of a Multicenter, Prospective, Open-Label, Noncomparative Study in Italy. [PDF]
Cagnacci A +8 more
europepmc +1 more source
Atogepant Has No Clinically Relevant Effects on the Pharmacokinetics of an Ethinyl Estradiol/Levonorgestrel Oral Contraceptive in Healthy Female Participants. [PDF]
Ankrom W +6 more
europepmc +1 more source

